Outcome of gastric cancer patients after successful gastrectomy
暂无分享,去创建一个
K. Hess | J. Ajani | A. Rashid | James C Yao | P. Pisters | P. Mansfield | James C. Yao | I. Schnirer | P. Rohatgi | J. Yao
[1] S. Sohn,et al. Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer , 2006, British Journal of Cancer.
[2] J. Roh,et al. A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer , 2006, Oncology.
[3] S. Park,et al. Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil , 2006, Anti-cancer drugs.
[4] L. Mariani,et al. Pathological features as predictors of recurrence after radical resection of gastric cancer , 2006, The British journal of surgery.
[5] J. Ajani,et al. Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Jeffrey W. Clark,et al. A Phase II Trial of Irinotecan in Patients with Previously Untreated Advanced Esophageal and Gastric Adenocarcinoma , 2005, Digestive Diseases and Sciences.
[7] J. Ajani. Evolving chemotherapy for advanced gastric cancer. , 2005, The oncologist.
[8] Marco Lorenzi,et al. Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer. , 2005, Hepato-Gastroenterology.
[9] J. Ajani,et al. Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Y. Nimura,et al. Survival after surgical treatment of early gastric cancer, surgical techniques, and long-term survival , 2005, Langenbeck's Archives of Surgery.
[11] G. Torre,et al. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2‐gastrectomy , 2005, Journal of surgical oncology.
[12] Dimitrios H Roukos,et al. Perspectives in the treatment of gastric cancer , 2005, Nature Clinical Practice Oncology.
[13] J. Macdonald. Treatment of localized gastric cancer. , 2004, Seminars in oncology.
[14] M. Akmansu,et al. Results of chemoirradiation after curative resection of locally advanced gastric cancer , 2004, International journal of clinical practice.
[15] Masahiko Watanabe,et al. Survival after surgical treatment of early gastric cancer: surgical techniques and long-term survival , 2004, Langenbeck's Archives of Surgery.
[16] J. Feinglass,et al. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. , 2003, Surgery.
[17] Aller,et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2002, The New England journal of medicine.
[18] J. Ajani,et al. CPT‐11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma , 2002, Cancer.
[19] S. Weeden,et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of MRC randomized surgical trial , 2001 .
[20] L. Oñate-Ocaña,et al. Survival benefit of D2 lymphadenectomy in patients with gastric adenocarcinoma , 2000, Annals of Surgical Oncology.
[21] P. Fayers,et al. Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial , 1999, British Journal of Cancer.
[22] S. Kim,et al. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer , 1998, Gastric Cancer.
[23] S. Groshen,et al. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy , 1997, Cancer.
[24] J. Chmiel,et al. Cancer of the stomach. A patient care study by the American College of Surgeons. , 1993, Annals of surgery.
[25] J. Ajani,et al. Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy , 1991, Cancer.
[26] H. Kalofonos,et al. Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study , 2005, Gastric Cancer.
[27] M. Huguier,et al. [Extended lymph-node dissection for gastric cancer]. , 1999, Chirurgie; memoires de l'Academie de chirurgie.
[28] S. Kim,et al. Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer , 1998 .